title: Prognostic factors in stage IB-IIA cervical carcinomas treated with postoperative radiotherapy.
abstract: OBJECTIVE
  This study investigated the prognostic significance of age, stage, tumor size, pelvic lymph node metastasis (PLM), surgical margin invasion, overall radiotherapy time (ORT), and interval between radiotherapy and surgery (IRS) in stage IB-IIA cervical carcinoma.
  
  
  METHODS
  100 patients treated with radical hysterectomy and postoperative radiotherapy were evaluated retrospectively.
  
  
  RESULTS
  The 5-yr overall survival (OS), disease-free survival (DFS), and pelvic control rate (PC) were 83.6%, 82.8%, and 91.8%, respectively. PLM (p=0.008), IRS (p=0.01), ORT (p=0.007), and tumor size (p=0.028) were found to be significant on PC. PLM (p=0.04), ORT (p=0.04), and IRS (p=0.001) were significant on OS. PLM was significant (p=0.04) and IRS was marginally significant (p=0.06) on DFS. After multivariate analysis, PLM was significant on OS, DFS and PC. Recurrences were seen in 14 patients.
  
  
  CONCLUSIONS
  According to this study PLM, IRS, and ORT are the most important prognostic factors. Recurrences outside the radiation volume leads to treatment failure.
authors.affiliation: Ankara University Medical School, Department of Radiation Oncology, Dikimevi, Turkey.
authors.forename: M
authors.initials: M
authors.lastname: Garipagaoglu
authors.forename: G
authors.initials: G
authors.lastname: Tulunay
authors.forename: M F
authors.initials: MF
authors.lastname: Kose
authors.forename: S
authors.initials: S
authors.lastname: Yalvac
authors.forename: F
authors.initials: F
authors.lastname: Kayikcioglu
authors.forename: A
authors.initials: A
authors.lastname: Cakmak
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D002277:Carcinoma / Q000401:mortality* / Q000532:radiotherapy / Q000556:secondary* / Q000601:surgery; D003131:Combined Modality Therapy; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000473:pathology; D009367:Neoplasm Staging; D011379:Prognosis; D018714:Radiotherapy, Adjuvant; D012189:Retrospective Studies; D016019:Survival Analysis; D002583:Uterine Cervical Neoplasms / Q000401:mortality* / Q000473:pathology* / Q000532:radiotherapy / Q000601:surgery